January 28, 2010
Draw a map of the brain when fear and anxiety are involved, and the amygdala—the brain's almond-shaped center for panic and fight-or-flight responses—looms large.
But the amygdala doesn’t do its job alone. Scientists at the Yerkes National Primate Research Center, Emory University, have recently built upon work from others, extending the fear map to part of the brain known as the prelimbic cortex.
Researchers led by Kerry Ressler, MD, PhD, found that mice lacking a critical growth factor in the prelimbic cortex have trouble remembering to fear electric shocks. The discovery could help improve diagnosis and treatment for anxiety disorders such as post-traumatic stress disorder and phobias.
The results are published online this week in the Proceedings of the National Academy of Sciences. Ressler is a researcher at Emory University's Yerkes National Primate Research Center, an associate professor of psychiatry and behavioral sciences at Emory University School of Medicine and a member of the Atlanta-based Center for Behavioral Neuroscience. He is the first practicing psychiatrist to be appointed a Howard Hughes Medical Investigator. The research was conducted in mice at the Yerkes Research Center.
Scientists describe the molecule BDNF (brain-derived neurotrophic factor) as Miracle-Gro for brain cells. It’s a protein that pushes brain cells to withstand stress and make new connections. In other parts of the brain such as the amygdala, interfering with BDNF’s effects blocks the acquisition of fear memory.
Some variations in the human gene for BDNF are thought to increase the risk for anxiety disorders and even change the anatomy of the prefrontal cortex in affected individuals.
“The prelimbic cortex is part of the medial prefrontal cortex, which appears to be important for emotional regulation in rodents as well as humans,” Ressler says. “Evidence is building that these regions may be dysregulated or even over-active in fear and anxiety disorders in humans.
Working with Ressler, postdoctoral associate Dennis Choi and colleagues took advantage of a strain of genetically engineered mice that lack the BDNF gene in certain parts of the brain. These include the prelimbic cortex but exclude the amygdala and other regions such as the hippocampus.
If mice are electrically shocked just after they hear a certain tone, they gradually learn to fear that tone, and they show that fear by freezing. The BDNF-altered mice could run around and respond to shocks just as well, and could still learn to fear tones “in the moment.”
However, they seemed to have trouble retaining fear memories as time passed. After learning to fear the tone, the altered mice didn’t freeze as much, compared to normal mice, one hour or a day later. Using a different approach, the researchers also found that mice injected with a virus that eliminates the BDNF gene in the prelimbic cortex display similar characteristics.
“This work is important for extending our understanding of how BDNF is important for neuronal plasticity, learning and memory,” Ressler says. ”Together with our previous work, these data suggest that preventing neural plasticity in very precise, but critical brain regions, can have vastly different effects on emotional memory.
“It is becoming increasingly clear that these prefrontal cortex regions are functionally associated with regions of the brain known for a long time to be involved in emotion, such as the amygdala and hippocampus,” he adds. ”Understanding the molecular and cellular mechanisms of these connections in rodent models will provide scientists a better understanding of how these similar areas are functioning in humans.”
A related paper in PNAS from Keqiang Ye, PhD, associate professor of pathology and laboratory medicine at Emory, and colleagues describes a family of compounds that can mimic BDNF.
The research was supported by the National Institutes of Health, the National Science Foundation, the National Alliance for Research on Schizophrenia and Depression and the Burroughs Wellcome Fund.
For nearly eight decades, the Yerkes National Primate Research Center, Emory University, has been dedicated to conducting essential basic science and translational research to advance scientific understanding and to improve the health and well-being of humans and nonhuman primates. Today, the center, as one of only eight National-Institutes of Health-funded national primate research centers, provides leadership, training and resources to foster scientific creativity, collaboration and discoveries. Yerkes-based research is grounded in scientific integrity, expert knowledge, respect for colleagues, an open exchange of ideas and compassionate quality animal care.
Within the fields of microbiology, immunology, neuroscience and psychobiology, the center’s research programs are seeking ways to: develop vaccines for infectious and noninfectious diseases, such as AIDS and Alzheimer’s disease; treat cocaine addiction; interpret brain activity through imaging; increase understanding of progressive illnesses such as Parkinson’s and Alzheimer’s; unlock the secrets of memory; determine behavioral effects of hormone replacement therapy; address vision disorders; and advance knowledge about the evolutionary links between biology and behavior.
The Robert W. Woodruff Health Sciences Center of Emory University is an academic health science and service center focused on missions of teaching, research, health care and public service. Its components include the Emory University School of Medicine, Nell Hodgson Woodruff School of Nursing, and Rollins School of Public Health; Yerkes National Primate Research Center; Winship Cancer Institute of Emory University; and Emory Healthcare, the largest, most comprehensive health system in Georgia. Emory Healthcare includes: The Emory Clinic, Emory-Children's Center, Emory University Hospital, Emory University Hospital Midtown, Wesley Woods Center, and Emory University Orthopaedics & Spine Hospital. The Woodruff Health Sciences Center has a $2.5 billion budget, 17,600 employees, 2,500 full-time and 1,500 affiliated faculty, 4,700 students and trainees, and a $5.7 billion economic impact on metro Atlanta.